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Abstract: Resonance Raman spectroscopy is used to document, for the first
time, a 6 cm−1 decrease of the Fe-S stretch by introducing an H-bond donor
into the proximal pocket of a cytochrome P450, which interacts with the key
cysteine thiolate axial ligand. The anticipated trans-effect on bound
exogenous ligands is also confirmed and evidence is obtained supporting
intimate interaction of the new histidyl-imidazole fragment with the heme
periphery.
Keywords: biophysics, heme proteins, oxidoreductases, Raman spectroscopy

Members of the widely distributed cytochrome P450 class of
monoxygenases, or CYPs, generate highly reactive oxygen-derived
intermediates that effect a diverse set of reactions, including
hydroxylation and epoxidation of relatively inert substrates,[1–3]
thereby facilitating such important physiological functions as steroid
biosynthesis and metabolism of pharmaceuticals.[4,5] The active site
heme b is bound by a proximal cysteine thiolate, while on the distal
side the heme is presented with an intricately arranged set of residues
facilitating proton transfer to ferric peroxo- and ferric hydroperoxospecies.[6] Substrate binding to the six coordinate, low-spin (6cLS)
ferric resting state converts it to a five-coordinate, high-spin state
(5cHS) that is reduced by natural redox partners, with the resulting
ferrous form then binding dioxygen. Normally, the enzymatic cycle
continues on to completion (oxidation of substrate) by accepting one
more electron from a reductase to generate a peroxo-intermediate.
Sequential delivery of two protons generates an initial hydroperoxointermediate and then the so-called Compound I, a potent oxidizing
species generally formulated as a ferryl heme π-cation radical.[1–3,7]
Understandably, there is considerable interest in gaining insight into
the structural factors that control the reactivity of the intermediates
encountered within this cycle.[8–10] One obvious point of interest is that
the strongly electron donating axial thiolate of all CYPs and structurally
related enzymes, such as Nitric Oxide Synthases (NOSs), can promote
O-O bond cleavage or impact the behavior of subsequent
intermediates.[11–15] The effective negative charge on this proximal
cysteine-thiolate could be fine-tuned by the nature and number of
suitably positioned H-bond donors known to be present in the proximal
pocket[14–23] A direct measure of the immediate consequences of such
H-bonding is documentation of the strength of the Fe-S linkage, a task
most readily accomplished by resonance Raman (rR) spectroscopy,
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using excitation within the S→ Fe charge transfer transition envelope
that occurs near 360 nm in the ferric HS form.[14,16–18,24–26] In the
present work this direct spectroscopic method is used to interrogate
active site structural changes that accompany a single site mutation of
a truncated form of CYP2B4; i.e., the F429H variant, where the highly
conserved proximal-side phenylalanine is replaced with the potentially
H-bonding histidyl residue. The essential results obtained provide new
definitive experimental evidence for the influence of proximal-side Hbonding on the key Fe-S linkage and its effects on the cytochrome
P450 cycle.
This F429H mutant is of great interest, because the presence of
this additional H-bond drastically diminished the enzyme’s ability to
promote O-O bond cleavage.[9] Additionally, computational studies
have suggested that the mutant’s heme oxygenase activity could arise
as a result of a predicted weakening of the Fe-S bond strength.[15]
Figure 1 shows the Soret band-excited rR spectra obtained for the
substrate-free (SF) and butylated hydroxytoluene (BHT)-bound “wild
type” ferric CYP2B4 and its F429H mutant. In the case of the WT
enzyme (traces A and B), substrate binding causes an almost complete
conversion from a 6cLS to 5cHS state; i.e. the ν3 “spin-state marker”
shifts from 1502 to 1487 cm−1.[27–29]

Figure 1

The low (left) and high (right) frequency rR spectra of ferric CYP2B4,

wild-type substrate-free (A), wild-type BHT-bound (B), F429H mutant substrate-free
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(C) and F429H mutant BHT-bound. Spectra measured with 406 nm excitation line and
normalized to the ν3 mode.

Similar behavior is documented for the F429H mutant, though
the conversion is not as complete. This residual 6cLS fraction seen for
the mutant might arise from decreased affinity for the substrate or
from a conformational heterogeneity that increases the stability of the
aquo-bound form. However, the absence of the SF form for the CO
adduct (vide infra) argues against the former case, unless one invokes
a significantly different substrate affinity between the ferric and
ferrous forms. In the low frequency region the bending modes
associated with the propionate and vinyl substituents are observed
near ~370 cm−1 and 400–440 cm−1, respectively. In contrast to
behavior seen for bacterial P450s,[16,30] only small shifts are typically
seen for microsomal mammalian CYPs such as those of interest
here,[26,31] whose distal pockets are larger and more flexible.[1,2] It is
noted, on the other hand, that BHT binding to both enzymes studied
here does activate out-of-plane (oop) modes at 318 and ~500 cm−1.
The key ν(Fe-S) mode is enhanced only via excitation within the
Fe-S charge transfer transition that occurs near 360 nm for the
(substrate-bound) ferric HS state.[24] Thus, in Figure 2 this mode is
observed as a relatively strong feature appearing at 353 cm−1 in the
BHT-bound WT enzyme and at 347 cm−1 for the BHT-bound CYP2B4
F429H. While the 347 cm−1 feature observed in the spectrum of the
F429H mutant is accidently degenerate with the 347 cm−1 feature seen
in with Soret excitation (Figure 1, Trace D left), the two features
correspond to two different modes; i.e., the ν(Fe-S) and the ν8 modes,
respectively. Convincing evidence for this is presented in the
Supporting Information, where it is shown that the observed
bandwidths are substantially broader for these 353/347 cm−1 features
than those observed for the heme modes (Figure S2).
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Figure 2

The low frequency rR spectra of ferric CYP2B4, wild-type BHT-bound (A)

and F429H mutant BHT-bound (B). Spectra measured with 356 nm excitation line and
normalized to the ν7 mode at 676 cm−1.

The observed 6 cm−1 shift of ν(Fe-S) to lower frequency for
F429H is qualitatively consistent with expectations based on the
reduction of effective negative charge on the thiolate, in agreement
with recent computations.[14,15] Similar earlier rR work with CYP101[17]
and CYP102,[16] led to unexpected results; i.e., removal of existing Hbond donors led either to no effect on the observed ν(Fe-S) frequency
or an unexpected decrease,[17] while an attempt to introduce a new Hbond donor residue to the proximal pocket of CYP102 (i.e., F393H)
failed to induce any observable shift of its ν(Fe-S) mode.[16] The
former result was later suggested to be attributable to vibrational
mode reorganization.[14] The absence of any changes on the ν(Fe-S)
mode for the F393H mutant of CYP102 was interpreted as evidence
that the histidyl residue was not in a proper orientation to H-bond to
the proximal cysteine thiolate fragment.[16,32] Given these
complications encountered in these previous rR studies, it is satisfying
that the present results agree with the predicted influence on the Fe-S
bond strength.[14,15]
The new H-bonding modulation of the Fe-S bond strength is also
reflected in the altered electronic structure of the trans-axial Fe-C-O
linkage of the ferrous CO adduct. Thus, as shown in Figure 3 (top), the
ν(Fe-C) shifts up by 3 cm−1 for the mutant (i.e., 463 → 466 and 473
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→476 cm−1 for the SF and BHT-bound comparisons), with the ν(C-O)
modes also shifting up by 5–7cm−1 for the same comparisons (i.e.,
1957 →1962 and 1945→1952 cm−1). These directly correlated shifts of
the ν(Fe-C) and ν(C-O) modes, both to higher frequency, are
indicative of a diminished σ-donation of the trans-axial proximal
thiolate ligand resulting from the newly introduced H-bonding histidine
residue, such behavior being in agreement with predictions made from
several high-level computational studies.[14,15,33] It is noted that earlier
computational work, supported with modest experimental data for
models, has previously been used to argue this point for the
isoelectronic ferric NO adducts.[34]

Figure 3

The low (left) and high (right) frequency rR spectra of ferrous CO adducts

of CYP2B4, wild-type substrate-free (A), wild-type BHT-bound (B), F429H mutant
substrate-free (C) and F429H mutant BHT-bound (D). Spectra measured with 442 nm
excitation line and normalized to the ν7 and ν4 modes for low and high frequency
region, respectively. The bottom graph shows linear correlation between ν(Fe-C) and
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ν(C-O) frequencies, the open squares represent wild type truncated CYP2B4,[40] the
solid squares indicate points for F429H mutants and the stars show mammalian
NOSs.[37–39]

Furthermore, the behavior seen here for the vibrational modes
of the Fe-C-O fragment is satisfyingly consistent with data reported for
CO adducts of NOS.[23] Thus, the plots shown at the bottom of Figure 3
present data acquired for CO adducts of mammalian NOS (stars), the
CO adducts of WT CYP2B4 under various conditions (open squares)
and the two points obtained here for the F429H mutant of CYP2B4
(solid squares); additional data reported for bacterial NOS proteins, as
well as the isoelectronic Fe(III)NO adducts of cytochromes P450 and
model compounds, are given in Figure S3 of Supporting Information.
The inverse correlations of the ν(Fe-C) and ν(C-O) modes are
generally accepted to reliably reflect variations in polarity of the distal
heme pocket,[33,35] with displacements from one another along the
vertical direction being the result of differences in the strength of the
proximal ligand. Thus, the displacement of the NOS line from the
CYP2B4 line arises because the Fe-S bonds of the NOSs are weakened
by the presence of an H-bond from a conserved tryptophan residue in
the proximal pocket; i.e., their ν(Fe-S) stretching frequencies
generally occur near 338 cm−1,[36] approximately 12–14 cm−1 lower
than for cytochromes P450. As can be seen in Figure 3, the points
derived for the F429H mutant of CYP2B4 indeed are shifted towards
the line for the NOS proteins, a shift entirely consistent with the
observed 6 cm−1 lowering of the ν(Fe-S) for this mutant.[37–39]
Finally, it is noteworthy that the remarkable structural
sensitivity of the rR technique reveals small, but clearly detectable,
mutation-induced changes for particular heme modes of the F429H
mutant. A complex difference pattern (Figure 4, trace C) is obtained
when comparing the rR spectra for the SF forms of ferrous CO adducts
of the WT and F429H mutant. A similar difference plot obtained for the
pair of BHT-bound forms is given in trace D. These data show that,
while the mutation does not significantly change the basic heme
structure, as reflected in the constancy of the core-sensitive ν3 and ν11
modes, changes are evident in the spectral region associated with the
ν(C=C) modes of the peripheral vinyl groups. The most reasonable
interpretation of these difference patterns is that the vinyl mode
envelope is shifted to slightly higher frequency, behavior which is
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consistent with out-of-plane displacement of the vinyl groups.[16] This
displacement diminishes the conjugation of the vinyl groups with the
heme macrocyle π-system, with the result that the ν2 core mode,
associated with stretching of the Cβ-Cβ bonds of the pyrrole ring to
which the vinyls are attached,[28] is also altered, experiencing an
increased resonance enhancement. Significantly, all of these changes
are observed for modes of molecular fragments localized at or near the
2- and/or 4-vinyl groups and are therefore entirely consistent with the
proposed interaction of the newly introduced histidyl imidazole with
the pyrrole A-ring, based on inspection of recently the acquired x-ray
crystal structure of the mutant.[LAW, unpublished]

Figure 4

The high frequency rR spectra of ferrous CO adducts of substrate-free

wild-type CYP2B4 (A) and F429H mutant (B). Spectra were normalized to the glycerol
mode at 1468 cm−1. The traces (C) and (D) are difference traces of ferrous CO
adducts of CYP2B4 wild-type and 429H mutant in substrate-free form (C) and in BHTbound state (D).

In summary, the present results show that the newly introduced
H-bond does indeed lead to a shift of the ν(Fe-S) stretching mode to
lower frequency, documenting a weakening of this bond, as predicted
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by theory.[14,15] Furthermore, the impact of this modulation of Fe-S
bond strength is transmitted to the heme iron linkage with a transaxial diatomic ligand (CO), as reflected in the observed behavior of the
ν(Fe-C) and ν(C-O ) modes of the Fe-C-O fragment,[23,41] such
electronic effects holding potential implications for functional
properties. Finally, changes in certain heme vibrational modes provide
convincing evidence for the presence of an intimate interaction
between the replacement residue, 429H, and the heme pyrrole A ring,
a structural feature that is suggested from inspection of preliminary Xray crystallographic data.[LAW, unpublished]

Experimental Section
Plasmid for the truncated mutant was constructed from pLW01wild type full length P4502B4 plasmid.[42] The cDNA coding for the 19
amino acids at the N-terminus (amino acids 3-21 of WT CYP2B4) were
removed using NcoI restriction sites which had been inserted at
position 3 and 21 by site directed mutagenesis. After removing the
cDNA between the two NcoI sites, the remainder of the plasmid was
religated by T4 DNA ligase (Invitrogen, NY). The following mutations,
E2A, G22K, H23K, P24T, K25S, A26S, H27K, R29K, H226Y and F429H
were then introduced into the Δ3–21 WT CYP2B4, using a QuikChange
Site-Directed Mutagenesis Kit (Stratagene) to generate the F429H
mutant of the truncated form of CYP2B4. The truncated form of
CYP2B4 (all of the mutations indicated above, minus the F429H
mutation), considered WT” above, is the form which had been
previously engineered to allow successful crystallization when bound to
different compounds.[43]
The plasmid pLW01 CYP450 2B4 F429H with cDNA for the
mutant or WT CYP2B4 was transformed into C41 (DE3) cells. The cells
were grown in TB medium at 23°C and induced with IPTG,
supplemented with delta-aminolevulinic acid at induction and ethanol
thirty minutes after induction. The induced cell culture was harvested
~120 hr after induction.
The protein samples were isolated and purified as previously
described.[44] Butylated hydroxytoluene (BHT) was added to all buffers
to prevent conversion to cytochrome P420 during purification. The
protein was eluted from hydroxyapatite column using buffer containing
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0.4 M K2HPO4/KH2PO4 pH 7.4 and 20% glycerol. The purified protein
was diluted into a final buffer containing 20% glycerol and 0.1 M
K2HPO4/KH2PO4 pH 7.4 and concentrated to ~1 mM using 50,000
MWCO VivaSpin 20.

The rR measurements
All samples are ~ 0.4mM in heme. All further details, including
solution conditions and spectrometer parameters are given in
Supporting Information.
Supplementary Material
Supporting Information
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